D-1326-2016 Class II Terminated
FDA drug recall D-1326-2016 was initiated by Pharmakon Pharmaceuticals, Inc. on Apr 20, 2016 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is terminated (terminated Jan 11, 2018). Affected quantity: 120.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 20, 2016
- Initiation Date
- Apr 20, 2016
- Termination Date
- Jan 11, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 120
Product description
HYDROmorphone HCI 0.2 mg/mL in 0.9% Sodium Chloride 50 mL fill in a 60 mL Monoject Syringe, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0933-75
Reason for recall
Lack of Assurance of Sterility
Distribution pattern
Nationwide VA/DOD: CA, KY, MD, NC, OK, TX, VA
Code information
All Sterile Compounded Products within Expiry
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1326-2016
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Pharmakon Pharmaceuticals, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.